These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23537267)

  • 21. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the Prevention and Treatment of High Altitude Illness.
    Davis C; Hackett P
    Emerg Med Clin North Am; 2017 May; 35(2):241-260. PubMed ID: 28411926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema.
    Wright A; Brearey S; Imray C
    Expert Opin Pharmacother; 2008 Jan; 9(1):119-27. PubMed ID: 18076343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors and high altitude illnesses.
    Swenson ER
    Subcell Biochem; 2014; 75():361-86. PubMed ID: 24146388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story.
    Swenson ER; Teppema LJ
    J Appl Physiol (1985); 2007 Apr; 102(4):1305-7. PubMed ID: 17194729
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetazolamide for the prophylaxis of acute mountain sickness.
    Imray C
    BMJ; 2012 Oct; 345():e7077. PubMed ID: 23114063
    [No Abstract]   [Full Text] [Related]  

  • 27. [Your patient wants to go to the mountains. You protect him from mountain sickness and altitude edema].
    MMW Fortschr Med; 2005 Apr; 147(14):4-5. PubMed ID: 15887670
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness.
    Dumont L; Tramer MR; Lysakowski C; Mardirosoff C; Kayser B
    High Alt Med Biol; 2003; 4(3):399; author reply 400. PubMed ID: 14561245
    [No Abstract]   [Full Text] [Related]  

  • 29. Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS; Pomeranz D; Burns P; Phillips C; Cheffers M; Evans K; Jurkiewicz C; Juul N; Hackett P
    Am J Med; 2018 Feb; 131(2):200.e9-200.e16. PubMed ID: 28668540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute mountain sickness and high-altitude pulmonary edema. How to protect the mountain climber from the effects of the "altitude haze"].
    Dehnert Ch; Schneider M; Mairbäurl H; Bärtsch P
    MMW Fortschr Med; 2003 Feb; 145(8):33-5. PubMed ID: 12661438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of acute mountain sickness.
    Wright AD
    J Clin Pharm Ther; 1987 Oct; 12(5):267-8. PubMed ID: 3680399
    [No Abstract]   [Full Text] [Related]  

  • 32. Acetazolamide and high altitude diseases.
    Bradwell AR; Wright AD; Winterborn M; Imray C
    Int J Sports Med; 1992 Oct; 13 Suppl 1():S63-4. PubMed ID: 1483796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS.
    Biondich AS; Joslin JD
    Wilderness Environ Med; 2016 Mar; 27(1):179-80. PubMed ID: 26520404
    [No Abstract]   [Full Text] [Related]  

  • 34. Acetazolamide: a treatment for chronic mountain sickness.
    Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude.
    Ritschel WA; Paulos C; Arancibia A; Agrawal MA; Wetzelsberger KM; Lücker PW
    Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):133-7. PubMed ID: 9604855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Altitude Illness: Dietary Implications.
    Morin KH
    MCN Am J Matern Child Nurs; 2016; 41(1):60. PubMed ID: 26658539
    [No Abstract]   [Full Text] [Related]  

  • 37. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
    Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
    Low EV; Avery AJ; Gupta V; Schedlbauer A; Grocott MP
    BMJ; 2012 Oct; 345():e6779. PubMed ID: 23081689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic mountain sickness: critical reappraisal of an old problem.
    Rivera-Ch M; León-Velarde F; Huicho L
    Respir Physiol Neurobiol; 2007 Sep; 158(2-3):251-65. PubMed ID: 17580125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Acetazolamide and Methazolamide on Exercise Performance in Normoxia and Hypoxia.
    Doherty CJ; Chang JC; Thompson BP; Swenson ER; Foster GE; Dominelli PB
    High Alt Med Biol; 2023 Mar; 24(1):7-18. PubMed ID: 36802203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.